BofA analyst Chase Mulvehill downgraded Core Laboratories to Underperform from Neutral with a $21.50 price target.
Published first on TheFly
BofA analyst Chase Mulvehill downgraded Core Laboratories to Underperform from Neutral with a $21.50 price target.
Published first on TheFly